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BACKGROUND: Neuroimaging studies of attention-deficit/hyperactivity disorder (ADHD) 
have most commonly reported volumetric abnormalities in the basal ganglia, cerebellum, 
and prefrontal cortices.  Few studies have examined the relationship between ADHD 
symptomatology and brain structure in population-based samples.  Herein, we 
investigate the relationship between dimensional measures of ADHD symptomatology, 
brain structure, and reaction time variability—an index of lapses in attention.  We also 
test for associations between brain structural correlates of ADHD symptomatology and 
maps of dopaminergic gene expression.   
METHODS: Psychopathology and imaging data were available for 1,538 youths.  Parent 
ratings of ADHD symptoms were obtained using the Development and Well-Being 
Assessment (DAWBA) and the Strengths and Difficulties Questionnaire (SDQ).  Self-
reports of ADHD symptomatology were assessed using the youth version of the SDQ.  
Reaction time variability was available in a subset of participants.  For each measure, 
whole brain voxel-wise regressions with gray matter volume (GMV) were calculated. 
RESULTS: Parent ratings of ADHD symptoms (DAWBA and SDQ), adolescent self-
reports of ADHD symptoms on the SDQ, and reaction time variability were each 
negatively associated with GMV in an overlapping region of the ventromedial prefrontal 
cortex (vmPFC).  Maps of DRD1 and DRD2 gene expression were associated with brain 
structural correlates of ADHD symptomatology.      
CONCLUSIONS: This is the first study to reveal relations between vmPFC structure and 
multi-informant measures of ADHD symptomatology in a large population-based sample 
of adolescents. Our results indicate that vmPFC structure is a biomarker for ADHD 
symptomatology.  These findings extend previous research implicating the default mode 
network and dopaminergic dysfunction in ADHD.     
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INTRODUCTION 
 
Attention-deficit/hyperactivity disorder (ADHD) is among the most prevalent 
neuropsychiatric disorders in youths, with roughly 3-7% of school-aged children meeting 
diagnostic criteria (1).  Longitudinal studies indicate that functionally impairing symptoms 
continue into adolescence and adulthood in approximately 60-80% of cases diagnosed 
during childhood (2, 3).  Extant morphometry studies on ADHD have implicated a 
number of anatomically related brain areas; however, findings have been somewhat 
inconsistent, with no common structural abnormality emerging across studies.  In adults 
and youths, structural abnormalities have been reported in the basal ganglia (4-10), 
prefrontal cortex (10-12), cerebellum (5, 10, 13, 14), anterior cingulate cortex (15), and 
less frequently reported in the hippocampus, amygdala, and thalamus (16, 17).  Several 
factors, however, may serve to obscure underlying brain-behavior relations in the study 
of ADHD symptomatology, including the use of categorical diagnoses, the lack of multi-
informant behavioral ratings, and small sample sizes.  In order to aptly characterize the 
neuroanatomical substrates of ADHD symptomatology, it is critical to demonstrate 
convergence across dimensional, multi-informant behavioral data using large population-
based samples.  If possible, findings should also demonstrate convergence with other 
established features of ADHD symptomatology across different domains—including 
measures of cognition, as well as neurochemistry.   
 
Over the last few decades, empirically based assessment of psychopathology has 
revealed aspects of dimensionality with regard to many psychiatric conditions, including 
ADHD (18).  Such findings have been somewhat difficult to reconcile with the categorical 
taxonomy espoused by the Diagnostic and Statistical Manual of Mental Disorders 
(DSM).  Although numerous studies have tested for brain differences between ADHD 
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patients and typically developing controls, few studies have investigated brain correlates 
of attention problems in the general population.  Following from a dimensional 
conceptualization of psychopathology, it is reasonable to postulate that both clinical and 
normative levels of a given psychiatric syndrome will be underpinned by overlapping 
neural substrates.  Mous et al. (2014) recently reported that cortical thickness in bilateral 
postcentral gyri was negatively associated with parent-reported attention problems in a 
population-based sample of 444 6- to 8-year-old children (19).  Ducharme et al. (2012) 
found that subclinical attention problems in typically developing youths, ranging from 6 to 
18 years of age, were associated with a decreased rate of cerebral cortical thinning 
within prefrontal and parietal cortical regions—brain areas that have been implicated in 
the pathophysiology of clinically significant attention problems (i.e., ADHD) (20-22).  
Similarly, Shaw et al. (2011) reported an association between subclinical symptoms of 
hyperactivity and impulsivity in typically developing youths and delayed cortical thickness 
maturation (23).  Such evidence supports the use of dimensional measures of 
psychopathology, as emphasized by the National Institute of Mental Health’s Research 
Domain Criteria program (24).  Taken together, there is compelling evidence that 
subclinical variation in ADHD symptomatology is tied to brain structure and 
development—and that these associations may be obfuscated by a strict categorical 
DSM approach.           
 
In the assessment of developmental psychopathology, informants represent an 
important source of variance (18).  The current DSM taxonomy does not offer clear, 
standardized methods for synthesizing reports from multiple informants.  Martel et al. 
(2015) recently reported that information from multiple informants increases the validity 
of assessing ADHD, and that averaging ratings is the optimal method for integrating 
multi-informant data (25).  Dimensional ratings from multiple informants also allow for 
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more sophisticated methods of integrating data, such as latent variable approaches. 
Unfortunately, few neuroimaging studies have utilized dimensional assessments of 
ADHD symptomatology from multiple informants.          
 
In addition to using quantitative, multi-informant behavioral ratings, we aimed to 
demonstrate convergence across different domains with measures previously 
associated with ADHD symptomatology.  Reaction time variability refers to the degree of 
intra-individual variation in responding to a target stimulus, and increased reaction time 
variability on attention tasks has been commonly reported in ADHD youths (26, 27). 
Lesion studies indicate that frontal lobe damage is accompanied by increased reaction 
time variability (28).  There is also evidence that individual differences in reaction time 
variability predict inhibitory success (29).  Further, subjects with increased reaction time 
variability exhibit greater activation within inhibitory regions of the brain during tasks of 
response inhibition (29).  Thus, reaction time variability may serve as an objective 
neurocognitive marker for ADHD symptomatology.  It remains unclear, however, the 
extent to which such cognitive measures are related to parent and self-report ratings of 
ADHD symptomatology, as well as brain structure, in the general population.   
 
Finally, patterns of gene expression may provide additional support in identifying 
potential brain-based markers for ADHD symptomatology.  The brai ’s dopami ergic 
system has been strongly implicated in a wide variety of cognitive functions including 
attention, and repeatedly linked to the pathophysiology of ADHD symptomatology.  
Indeed, a number of medications that have proven efficacious in the treatment of ADHD 
work by blocking dopamine reuptake and/or stimulating dopamine release, increasing 
extracellular dopamine levels.  It is reasonable to postulate that regions of the brain that 
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are volumetrically related to ADHD symptomatology will be tied the expression of genes 
encoding for dopaminergic receptors.        
 
Herein, we investigate the relationship between dimensional measures of ADHD 
symptomatology and brain structure in a large population-based sample of adolescents, 
utilizing multi-informant behavioral ratings.  In a subset of participants, we also 
investigate relations between reaction time variability, measures of ADHD 
symptomatology, and brain structure.  Finally, utilizing publicly available gene expression 
data collected as part of the Allen Human Brain Atlas (30), we test the extent to which 
the relationship between brain structure and ADHD symptomatology is correlated with 
patterns of dopaminergic gene expression.  To our knowledge, the following represents 
the first voxel-based morphometry (VBM) of ADHD symptomatology using a population-
based sample of youths.  
 
METHODS AND MATERIALS 
 
Sample 
 
Neuroimaging and behavioral data were obtained from the IMAGEN study conducted 
across 8 European sites in France, the United Kingdom, Ireland, and Germany, which 
includes 2,223 adolescents recruited from schools at age 14 years (SD = 0.41 year; age 
range = 12.9–15.7 years). A detailed description of recruitment and assessment 
procedures has been published elsewhere (31).  In the present study, a total of 1,538 
participants possessed multi-informant psychopathology data, quality controlled 
neuroimaging data, and complete demographic data (Table 1).  Behavioral data for the 
stop signal task (SST) were only available in a subset of participants (N = 767). 
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Psychopathology Assessment 
 
The Development and Well-Being Assessment (32) is a computer-based package of 
questionnaires, interviews, and rating techniques used to assess adolescent 
psychopathology.  In the present study, ADHD symptom counts were derived from the 
parent version of the DAWBA—youths did not complete the DAWBA ADHD module.  In 
addition to total symptom count, the parent version of the DAWBA yielded separate 
symptom counts for both Hyperactivity/Impulsivity and Inattention. 
 
Self-report and parent report versions of the Strengths and Difficulties Questionnaire 
(SDQ) were also used to assess symptoms of hyperactivity and inattention (33).  In 
addition to the Hyperactive/Inattentive scale, the Emotional scale on the youth SDQ was 
utilized to assess mood and anxiety symptomatology.  The SDQ is a reliable and valid 
measure of youth emotional and behavior symptoms, on which scores are predictive of 
increased probability of clinician-rated psychiatric disorders and retest stability over 4-6 
months (34).  
 
Behavioral Measures 
 
Behavioral data from the functional imaging stop signal task (SST) were utilized in the 
present study.  Associations were tested between ADHD symptom scores (both DAWBA 
and SDQ) and several SST measures including mean reaction time, stop signal reaction 
time (SSRT), and reaction time variability.  The standard deviation of “Go” reaction time 
on the SST was used to assess reaction time variability in participants.   
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Demographic Measures 
 
The puberty development scale (PDS) was used to assess the pubertal status of 
participants (35).  The socioeconomic status (SES) score was derived by summing the 
followi g variables:  other’s Educatio  Score, Father’s Educatio  Score, Family Stress 
Unemployment Score, Financial Difficulties Score, Home Inadequacy Score, 
Neighborhood Score, Financial Crisis Score, Mother Employed Score, and Father 
Employed Score (36).  
 
MRI acquisition  
 
MRI scanning was conducted at the eight IMAGEN assessment sites using 3T whole 
body MRI systems (31).  See supplemental information for further details. 
 
Structural MRI 
 
High-resolution anatomical MRIs were acquired with a three-dimensional T1-weighted 
magnetization prepared gradient echo sequence (MPRAGE) based on the ADNI 
protocol (http://www.loni.ucla.edu/ADNI/Cores/index.shtml). 
 
MRI data preprocessing  
 
Preprocessing of the structural T1-weighted data was performed with Statistical 
Parametric Mapping version 8 (Wellcome Department of Neuroimaging, London, United 
Kingdom, http://www.fil.ion.ucl.ac.uk/spm/software/spm8/), using standard automated 
pipelines (31).  See supplemental information for details.  
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Statistical Analyses 
 
Whole brain voxel-wise analyses were conducted using the general linear model, 
performed with the VBM toolbox of SPM8.  Age, gender, total gray matter volume 
(GMV), site, pubertal development, Performance IQ, Verbal IQ, and SES were controlled 
for in each model.  For all analyses, an initial height threshold of p ≤ .005 was 
implemented at the voxel level, with a corrected family-wise error (FWE; p ≤ .05) 
subsequently applied to identify significant clusters.  It should be noted that for the VBM 
analyses outlined below, results were not meaningfully altered when adopting an initial 
height threshold of p ≤ .001.       
 
Latent Variable Analysis 
 
Latent variable analysis has been proposed as a powerful method for incorporating 
multi-informant reports of psychopathology as predictor variables in regression modeling 
(37).  In the present study, confirmatory factor analysis was carried out using the 
package Lavaan in R (38).  In particular, a latent ADHD symptom variable was derived 
from the observed multi-informant measures.  Observed measures included parent- and 
self-reports of ADHD symptomatology on the SDQ, as well as the ADHD symptom 
counts based on the parent version of the DAWBA.  
 
Gene Expression  
 
Finally, relations between the structural correlates of ADHD symptomatology and gene 
expression were examined.  In order to test for associations between gene expression 
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and brain structural correlates of ADHD symptoms, we used a brain map derived from 
regressions between GMV and the mean composite of multi-informant behavioral 
ratings.  This decision was based on previous research indicating that averaging 
symptom ratings across multiple informants appears optimal relative to other 
approaches such as structural equation modeling (25).  The unthresholded t-statistic 
map, resulting from regressing regional gray matter volume against the mean composite 
of multi-informant ratings, was subsequently tested for associations with patterns of 
gene expression.  Using the alleninf toolbox (39) and gene expression data collected for 
the Allen Human Brain Atlas (30), we tested for an association with several 
dopaminergic genes that have been previously implicated in ADHD symptomatology: 
DRD1, DRD2, and DRD4.  In brief, the toolbox extracts the MNI coordinates of each 
gene expression sampling site, draws a spherical ROI (r = 4 mm) and averages values 
of the statistical map within each spherical ROI.  Average ROI values are then correlated 
with normalized gene expression values.  Further details can be found elsewhere (39).        
    
RESULTS 
 
Demographic and Behavioral Measures 
 
Demographic information for participants is provided in Table 1.  Correlations between 
multi-informant ratings (including mean composite and latent ADHD measures) and 
reaction time variability are listed in Table 2. 
 
Both parent and youth ratings of ADHD symptomatology were inversely correlated with 
SES (ranging from r = -0.095 to r = -0.193), as well as Performance and Verbal IQ 
(ranging from r = -0.107 to r = -0.231).  In addition, parent ADHD ratings on the DAWBA 
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and SDQ were inversely correlated with pubertal stage (ranging from r = -0.107 to r = -
0.112).  Males, on average, also possessed significantly higher ADHD symptom ratings, 
but only on the DAWBA (t = 5.86, p < 0.001) and parent SDQ (t = 6.66, p < 0.001).   
 
Imaging Analyses 
 
DAWBA Symptom Count. Regressing regional gray matter volume against total ADHD 
symptom count—based on parent reporting on the DAWBA—revealed a negative 
association in bilateral ventromedial and orbital lateral prefrontal cortices (3424 voxels, x 
= -4, y = 30, z = -20; peak Z score = 4.12) (Figures 1 and 2).  The effect size for this 
association was f2 = 0.01.  No other associations survived correction for multiple 
comparisons.   
 
Follow up analyses were conducted using Hyperactive/Impulsive and Inattentive 
symptom counts on the DAWBA. Hyperactive/Impulsive and Inattentive symptom counts 
on the DAWBA were positively correlated (r = 0.57, p = 2.93×10-130).  When analyzed 
separately, Inattentive symptoms were negatively associated with gray matter volume in 
bilateral ventromedial and left orbital lateral prefrontal cortices (2906 voxels, x = -4, y = 
28, z = -20; peak Z score = 4.58), and Hyperactive/Impulsive symptoms were negatively 
associated with gray matter in the left superior temporal gyrus (STG), left posterior 
insula, and left parietal operculum (2006 voxels, x = -63, y = -16, z = 4; peak Z score = 
4.16) (Figure 2).  No other associations survived correction for multiple comparisons.  
Results were not altered when covarying for self-reported mood and anxiety 
symptomatology on the SDQ.        
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Parent SDQ. Regression analysis revealed a negative association between the 
Hyperactivity/Inattention subscale score on the parent version of the SDQ and gray 
matter volume in bilateral ventromedial prefrontal cortices (1887 voxels, x = 10, y = 38, z 
= -15; peak Z score = 4.86) (Figures 1 and 2).  The effect size for this association was f2 
= 0.01.  No other associations survived correction for multiple comparisons.  Again, 
results were not changed when controlling for self-reported mood and anxiety 
symptomatology on the SDQ.        
  
Youth SDQ. Regressing regional gray mater volume against the 
Hyperactivity/Inattention subscale score on the youth self-report version of the SDQ 
revealed a negative association in bilateral ventromedial and right orbital lateral 
prefrontal cortices (2576 voxels, x = 9, y = 33, z = -15; peak Z score = 3.73) (Figure 1). 
The effect size for this association was f2 = 0.02.  No other associations survived 
correction for multiple comparisons.  Results were not changed when controlling for self-
reported mood and anxiety symptomatology on the SDQ.        
 
Latent Variable. Regional gray matter volume was regressed against factor loadings on 
the latent ADHD symptom variable, derived using confirmatory factor analysis.  Factor 
loadings on the latent variable were negatively associated with gray matter volume in 
bilateral ventromedial prefrontal cortices (3210 voxels, x = 9, y = 33, z = -17; peak Z 
score = 4.96) (See Supplementary Figure S1).  The effect size for this association was f2 
= 0.01.  The Dice Similarity Coefficient (DSC) was calculated in order to quantify the 
spatial overlap between results obtained using the latent ADHD variable and each of the 
three ADHD behavioral rating measures described above (DAWBA, parent SDQ, youth 
SDQ).  Based on image validation literature, a good overlap occurs when DSC >0.70 
(40). The DSC was high when comparing results obtained with the latent ADHD variable 
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and both the DAWBA and parent SDQ (0.72 and 0.73, respectively); however, the DSC 
was considerably lower when comparing with the youth SDQ (0.29).   
 
Supplementary Figure S1 depicts the relationship between regional gray matter volume 
and the CFA-derived latent ADHD variable, as well as a composite ADHD score 
calculated by averaging across multi-informant data on the SDQ and DAWBA.  The 
correlation between CFA-derived latent ADHD variable and the composite ADHD score 
was very high, r = 0.94, p < 0.001.  Again, the DSC was calculated in order to quantify 
the spatial overlap between the multi-informant averaging method and the latent variable 
approach.  The DSC for the two maps was equal to 0.71.  
 
Stop Signal Task. Mean reaction time and SSRT were not related to measures of 
ADHD symptomatology.  However, each measure of ADHD symptomatology was 
positively correlated with reaction time variability (r = 0.11 - 0.14) (See Table 2).  
Regressing regional gray matter volume against reaction time variability in a subset of 
participants with available behavioral data (N = 767) revealed a negative association in 
bilateral medial prefrontal cortices, including dorsal portions of the anterior cingulate 
gyrus (5007 voxels, x = 9, y = 50, z = 12; peak Z score = 3.85).  The effect size for this 
association was f2 = 0.03.  No other associations survived correction for multiple 
comparisons (Figure 1).  Figure 3 depicts the region in which gray matter volume was 
negatively associated with reaction time variability, as well as all each of the three 
behavioral rating measures (center-of-gravity for region of overlap, x = 3.13, y = 34.42, z 
= -14.84). 
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Gene Expression 
 
The statistical map resulting from regressing regional gray matter volume against the 
mean composite of multi-informant ratings (Supplementary Figure S2) was associated 
with DRD1 (r = -0.27, p = 2.0 × 10-54) and DRD2 expression (r = 0.09, p = 1.9 × 10-7) 
(Figures 4 and 5).  DRD4 expression was not associated with brain areas that were 
related to ADHD symptomatology. 
 
DISCUSSION 
 
To our knowledge, this is the largest population-based structural imaging study on 
ADHD symptomatology to date.  Parent and youth ratings of ADHD symptomatology 
were all negatively associated with gray matter volume in an overlapping portion of the 
vmPFC.  Critically, our findings were not changed when measures of mood and anxiety 
symptomatology were controlled for in analyses.  When analyzing 
Hyperactivity/Impulsivity and Inattention symptom counts separately, we found that 
Inattention symptoms were associated with reduced volume in bilateral vmPFC, whereas 
Hyperactive/Impulsive symptoms were related to reduced gray matter volume in the left 
superior temporal gyrus, parietal operculum, and posterior insula.  Thus, reduced gray 
matter volume in ventromedial prefrontal cortices appears to be particularly tied to 
aspects of inattentive symptomatology in adolescents.  In line with this interpretation, we 
found that reaction time variability—posited to reflect lapses in attention as opposed to 
hyperactivity—was negatively associated with gray matter volume in an overlapping 
region of the vmPFC.  Given convergence across dimensional, multi-informant 
behavioral ratings, and a measure of neurocognitive functioning that has been previously 
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tied to ADHD, our findings indicate that vmPFC structure is a brain-based marker for 
attention problems in adolescents.   
 
In the largest VBM study to date on adult ADHD, a significant negative correlation was 
revealed between vmPFC gray matter volume and dimensional measures of ADHD 
symptomatology (41).  Specifically, when analyzing patients and controls together, the 
authors found an inverse relationship between dimensional measures of ADHD 
symptomatology and vmPFC gray matter volume.  Inattentive symptoms, in particular, 
were negatively correlated with gray matter volume in the vmPFC (41).  Strikingly, the 
findings of Maier et al. (2015) largely overlap with the results of the present study.  
Taken together, reduced gray matter in the vmPFC may serve as a marker for attention 
problems in both adolescent and adult populations. 
 
Increased reaction time variability on tasks of vigilant attention has been a common 
finding when comparing children with ADHD versus typically developing controls (26, 
27).  This finding has led others to hypothesize that increased reaction time variability is 
tied to aberrant default mode network (DMN) activity (42).  In particular, the default-
mode interference hypothesis posits that activity in the DMN, which is typically 
attenuated during goal-directed tasks, can persist into periods of task-related processing 
and, as a result, compete with task-specific neural processing (42).  The vmPFC 
represe ts a primary hub i  the brai ’s default mode  etwork (D N)—a network posited 
to play a central role in mind-wandering and task-unrelated thought.  Although 
speculative, it is possible that the volumetric reductions in the vmPFC may be linked to 
DMN dysfunction.  In a recent study by Salavert et al. (2015), ADHD participants 
exhibited reduced deactivation of the medial prefrontal cortex during a working memory 
task.  The authors suggest that failure to deactivate the medial prefrontal cortex is tied to 
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lapses of attention, and that this may be a central feature of ADHD symptomatology.  It 
is possible that findings in the present study are tied to DMN dysfunction, and, more 
specifically, reduced vmPFC gray matter volume may be related to an impaired ability to 
deactivate portions of the DMN.  Future studies are needed to test this possibility.             
 
It is noteworthy that, despite modest correlations between multi-informant behavioral 
ratings (r = 0.36-0.66), we observed striking convergence with regard to brain structural 
correlates.  Similarly, reaction time variability was modestly correlated with behavioral 
ratings of ADHD symptomatology (r = 0.11-0.14), and, again, we observed considerable 
overlap with regard to anatomical correlates.  These findings suggest that the vmPFC is 
tied to both parental and youth self-reports of ADHD symptomatology, as well as an 
objective behavioral measure of ADHD symptomatology (i.e., reaction time variability).     
 
In the present study, two different methods were used to analyze multi-informant ratings 
of adolescent attention problems.  First, a composite ADHD symptom score was created 
by averaging multi-informant behavioral ratings.  Averaging multi-informant ratings of 
ADHD symptomatology has been found by others to be the optimal method for 
integrating multi-informant data (25).  Second, confirmatory factor analysis was used to 
derive a latent ADHD symptom variable based on multi-informant DAWBA and SDQ 
data.  To our knowledge, this is the first neuroimaging study to directly compare these 
two methods of handling multiple-informant behavioral data.  In short, we found that 
these two methods yielded very similar results when relating to regional gray matter 
volume, producing statistical maps with a high degree of spatial overlap.   
 
We found that the statistical map representing the relationship between GMV and ADHD 
symptomatology was significantly correlated with patterns of dopaminergic gene 
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expression.  More specifically, areas of the brain in which ADHD symptomatology was 
inversely associated with GMV tended to be regions that expressed the gene that 
encodes for the D1 dopamine receptor, DRD1.  This finding is particularly intriguing 
given that D1 receptor density in the cortex has been recently linked to the functional 
decoupling of DMN and task-positive networks in humans (43).  Thus, D1 receptor 
density in the vmPFC—a major hub of the DMN—may be particularly relevant with 
regard to ADHD symptomatology, affecting the dynamic interplay between task-negative 
and task-positive networks.  Candidate gene studies have also tied DRD1 to symptoms 
of inattention (44).  Brain areas showing reduced volume at higher levels of ADHD 
symptomatology were characterized by relatively low DRD2 expression.  It is unclear 
why DRD1 and DRD2 expression patterns were differentially associated with our VBM 
results.  It is possible that these findings can be explained, in part, by the differential 
distribution of D1 and D2 receptors in the human brain (45).  Previous research indicates 
a dorsolateral-ventromedial gradient with regard to the respective distribution of D1 and 
D2 receptors, with D1 receptors being more prevalent in ventromedial regions of the 
striatum and cortex (45, 46).  This differential distribution of D1 and D2 receptors is also 
believed to reflect a disti ctio  betwee  “direct” a d “i direct” cortico-striatal-thalamic-
cortical circuits—with D1 receptors playi g a more importa t role i  “direct” circuits that 
serve to disinhibit thalamic activity and initiate behavior, and D2 receptors playing a 
greater role i  “i direct” circuits that serve to i hibit neuronal activity (46-48).  Although 
speculative, the results of our follow-up gene expression analyses may reflect a relative 
imbalance between D1 and D2 systems.  However, it is important to emphasize that 
these gene expression analyses are meant to be hypothesis-generating in nature.  It is 
critical that future studies more directly test these possibilities.          
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Before concluding, it is important to address limitations of the present study.  First, given 
that we have focused on regional gray matter volume in our analyses, we are unable to 
definitively comment on the neurophysiological underpinnings of our VBM findings.  
Similarly, we are unable to comment on possible ties to aberrant structural and/or 
functional connectivity.  Second, patterns of gene expression are related to age and 
developmental stage, and our gene expression analyses do not capture these age-
related influences.  Third, it is worth noting that, across all analyses, observed effect 
sizes were small.  This may reflect that the vmPFC findings in the present study 
co stitute o e part i  the full elucidatio  of ADHD’s brai -based correlates.  Fourth, we 
observed an apparent dissociation with regard to the neuroanatomical correlates of 
hyperactive/impulsive and inattentive symptomatology.  It is possible, however, that 
differences in statistical power may have influenced these results—in particular, more 
variance was observed in inattentive symptoms (M = 2.64, SD = 3.86) relative to 
hyperactive/impulsive symptoms (M = 1.42, SD = 2.65).  
 
Taken together, reduced volume in the vmPFC may serve as a relatively stable 
biomarker for inattention.  The present study lays the foundation for informing early 
intervention and prevention efforts.  One exciting future direction will be to examine the 
extent to which vmPFC structure during adolescence predicts subsequent symptom 
trajectories into adulthood.  This work has the exciting potential to identify brain-based 
markers for future outcomes, helping to target youths at greatest risk for poor outcomes.  
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TABLE 1: Summary statistics for predictor variables. 
Age (in years) (Mean ± SD) 14.53 ± 0.41 
Gender 51% F (785), 49% M (753) 
SES  (Mean ± SD) 17.80 ± 4.06 
Verbal IQ  (Mean ± SD) 110.94 ± 14.88 
Performance IQ  (Mean ± SD) 108.16 ± 14.87 
DAWBA Symptom Count  (Mean ± SD) 4.05 ± 5.79 
H/I Score on Parent SDQ  (Mean ± SD) 2.94 ± 2.27 
H/I Score on Youth SDQ  (Mean ± SD) 3.94 ± 2.15 
Reaction Time Variability (Mean SD ± SD) 101.49 ± 24.96 (N = 767) 
 
 
N= 1,538 unless otherwise noted; H/I = Hyperactive/Inattentive scale 
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TABLE 2: Bivariate correlations between behavioral and cognitive measures of ADHD 
symptomatology. 
  
 
 
  
Parent 
SDQ DAWBA 
Reaction 
Time 
Variability  
Composite 
ADHD 
Latent 
Variable 
Youth SDQ Pearson 
Correlation 
*.430 *.359 *.139 *.736 *.518 
Sig. (2-
tailed) 
p <.001 p <.001 p <.001 p <.001 p <.001 
N 1538 1538 767 1538 1538 
Parent SDQ Pearson 
Correlation  
*.661 *.139 *.861 *.973 
Sig. (2-
tailed)  
p <.001 p <.001 p <.001 p <.001 
N 
 
1538 767 1538 1538 
DAWBA Pearson 
Correlation   
*.108 *.832 *.802 
Sig. (2-
tailed)   
p <.005 p <.001 p <.001 
N 
  
767 1538 1538 
Reaction Time 
Variability 
Pearson 
Correlation    
*.159 *.149 
Sig. (2-
tailed)    
p <.001 p <.001 
N 
   
767 767 
Composite 
ADHD 
Pearson 
Correlation     
*.944 
Sig. (2-
tailed)     
p <.001 
N 
    
1538 
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FIGURE 1: 
 
Results from whole brain voxel-wise analyses.  Age, gender, total gray matter volume 
(GMV), site, pubertal development, Performance IQ, Verbal IQ, and socio-economic 
status were controlled for in the analyses.  An initial height threshold of p ≤ .005 was 
implemented at the voxel level, with a corrected family-wise error (FWE; p ≤ .05) 
subsequently applied to identify significant clusters.  To visualize overlap in findings. the 
image on the right is a composite of all associations.  
 
FIGURE 2: 
 
Results from whole brain voxel-wise analyses using Hyperactive/Impulsive and 
Inattentive symptom counts.  Age, gender, total gray matter volume (GMV), site, pubertal 
development, Performance IQ, Verbal IQ, and socio-economic status were controlled for 
in the analyses.  An initial height threshold of p ≤ .005 was impleme ted at the voxel 
level, with a corrected family-wise error (FWE; p ≤ .05) subseque tly applied to ide tify 
significant clusters. 
 
FIGURE 3: 
 
Figure illustrates region of overlap between parent DAWBA, parent SDQ, youth SDQ, 
and reaction time variability.  Age, gender, total gray matter volume (GMV), site, pubertal 
development, Performance IQ, Verbal IQ, and socio-economic status were controlled for 
in the analyses.  An initial height threshold of p ≤ .005 was impleme ted at the voxel 
level, with a corrected family-wise error (FWE; p ≤ .05) subseque tly applied to ide tify 
significant clusters. 
 
FIGURE 4: 
 
Scatter plot depicting the relationship between normalized gene expression values (y 
axis) and t-statistic value (x axis) corresponding to the association between gray matter 
volume (GMV) and multi-informant average of ADHD symptoms. Positive t values 
indicate an inverse association between GMV and symptomatology, whereas negative t 
values represent a positive association between GMV and ADHD symptomatology.  
 
 
FIGURE 5: 
 
Scatter plot depicting the relationship between normalized gene expression values (y 
axis) and T-statistic value (x axis) corresponding to the association between gray matter 
volume (GMV) and multi-informant average of ADHD symptoms.  Positive t values 
indicate an inverse association between GMV and symptomatology, whereas negative t 
values represent a positive association between GMV and ADHD symptomatology.   
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